The effectiveness of anticonvulsants in psychiatric disorders

Figures & data

Table I. Evidence from monotherapy and add-on studies for the efficacy of anticonvulsants in psychiatric and neuropsychiatrie disorders. Evidence; +++, evidence from at least two randomized, placebo-controlled studies; ++, evidence from one placebo-controlled study or at least two randomized comparator studies or a systematic metaanalysis; +, evidence from only one comparator study, open studies; 0, not tested (or no published results); -, negative evidence. GAD, generalized anxiety disorder; PD, panic disorder; SP, social phobia; PTSD, post-traumatic stress disorder; MDD, (a) = major depressive disorder (= unipolar depression), acute treatment; MDD, (p) = major depressive disorder (= unipolar depression), prophylactic treatment; BPm, bipolar disorder, manic; BPd = Bipolar disorder, depressed; BPp = Bipolar disorder, prophylaxis; BPD, borderline personality disorder; PHN, postherpetic neuralgia